loading
Acurx Pharmaceuticals Inc stock is traded at $0.3801, with a volume of 333.94K. It is down -6.84% in the last 24 hours and down -11.60% over the past month. Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.
See More
Previous Close:
$0.408
Open:
$0.42
24h Volume:
333.94K
Relative Volume:
0.06
Market Cap:
$11.26M
Revenue:
-
Net Income/Loss:
$-14.58M
P/E Ratio:
-0.3305
EPS:
-1.15
Net Cash Flow:
$-9.80M
1W Performance:
-20.81%
1M Performance:
-11.60%
6M Performance:
-47.93%
1Y Performance:
-83.03%
1-Day Range:
Value
$0.38
$0.422
1-Week Range:
Value
$0.38
$0.465
52-Week Range:
Value
$0.30
$2.39

Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile

Name
Name
Acurx Pharmaceuticals Inc
Name
Phone
917-533-1469
Name
Address
259 LIBERTY AVENUE, STATEN ISLAND
Name
Employee
4
Name
Twitter
Name
Next Earnings Date
2025-03-18
Name
Latest SEC Filings
Name
ACXP's Discussions on Twitter

Compare ACXP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ACXP
Acurx Pharmaceuticals Inc
0.3801 12.03M 0 -14.58M -9.80M -1.15
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
467.53 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
556.44 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.20 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
593.35 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
304.27 31.54B 3.81B -644.79M -669.77M -6.24

Acurx Pharmaceuticals Inc Stock (ACXP) Latest News

pulisher
07:54 AM

How moving averages guide Acurx Pharmaceuticals Inc. tradingDaily Stock Movement Forecast with Accuracy - Newser

07:54 AM
pulisher
06:14 AM

Why Acurx Pharmaceuticals Inc. stock attracts strong analyst attentionSmart Trade Mapping with Entry Details - Newser

06:14 AM
pulisher
Jul 28, 2025

What makes Acurx Pharmaceuticals Inc. stock price move sharplyFree Swing Setup With Technical Confirmation - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is Acurx Pharmaceuticals Inc. company’s balance sheetSwing Trade Entry Points For Fast Growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does Acurx Pharmaceuticals Inc. stock perform well during market downturnsExceptional stock performance - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Technical signs of recovery in Acurx Pharmaceuticals Inc. Volume Confirmed Setup with Entry Confidence - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

What high frequency data says about Acurx Pharmaceuticals Inc.Free Sector Based Breakout Stock Forecast - Newser

Jul 28, 2025
pulisher
Jul 28, 2025

Is Acurx Pharmaceuticals Inc. stock overvalued or undervaluedPost Market Recommendation For 2025 - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Can volume confirm reversal in Acurx Pharmaceuticals Inc.Free Risk Controlled Short Term Trade Plans - Newser

Jul 28, 2025
pulisher
Jul 27, 2025

What are Acurx Pharmaceuticals Inc. company’s key revenue driversAchieve rapid capital gains with smart investing - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are the latest earnings results for Acurx Pharmaceuticals Inc.Maximize portfolio growth with professional advice - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What risks could impact Acurx Pharmaceuticals Inc. stock performanceElite Investor Club - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

Moving Average Trends for Acurx Pharmaceuticals Inc. Stock: What They IndicateInstant Stock Updates - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

How Acurx Pharmaceuticals Inc. stock performs during market volatilityReliable High Profit Alerts - Newser

Jul 27, 2025
pulisher
Jul 25, 2025

Is Acurx Pharmaceuticals Inc. a good long term investmentOutstanding risk-reward balance - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Acurx Pharmaceuticals Inc. stock priceHigh-margin investment plays - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Acurx Pharmaceuticals Faces AI-Driven Challenges Amid Regulatory and Cybersecurity Concerns - TipRanks

Jul 25, 2025
pulisher
Jul 24, 2025

What analysts say about Acurx Pharmaceuticals Inc. stockFree Predictions - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

Acurx Pharmaceuticals Earnings: Antibiotic Developer to Reveal Q2 2025 Results and Pipeline Progress - Stock Titan

Jul 24, 2025
pulisher
Jul 24, 2025

Acurx Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 12, 2025 Conference Call and Provide Business Update - Ariva

Jul 24, 2025
pulisher
Jul 22, 2025

Acurx Pharmaceuticals Inc. Stock Analysis and ForecastExceptional profit margins - jammulinksnews.com

Jul 22, 2025

Acurx Pharmaceuticals Inc Stock (ACXP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Acurx Pharmaceuticals Inc Stock (ACXP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Sailer Carl
Director
Jan 06 '25
Buy
1.01
24,631
25,000
137,183
LUCI DAVID P
President and CEO
Jan 06 '25
Buy
1.01
49,261
50,000
1,097,458
Donohue James J.
Director
Jan 06 '25
Buy
1.01
9,852
10,000
22,352
DELUCCIA ROBERT J
Director
Jan 06 '25
Buy
1.01
49,261
50,000
1,010,196
DEAN JACK H
Director
Jan 06 '25
Buy
1.01
9,852
10,000
21,776
$75.76
price up icon 7.98%
$37.32
price up icon 0.67%
$103.93
price up icon 2.04%
$26.76
price down icon 2.91%
$110.05
price down icon 2.43%
biotechnology ONC
$303.89
price up icon 3.22%
Cap:     |  Volume (24h):